Last reviewed · How we verify
gucy2c cart cells
At a glance
| Generic name | gucy2c cart cells |
|---|---|
| Sponsor | Innovative Cellular Therapeutics Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- CART Therapy in GUCY2C-positive Digestive Tract Tumors (EARLY_PHASE1)
- CART Therapy in Digestive System Tumors (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |